← Open Payments lookup

STEPHEN ANAYA: Open Payments

NPI 1992478507 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$241 in 12 payments from 9 companies in 2025. Trend: 2023 $465 · 2024 $169 · 2025 $241

Food & beverage: $241
CompanyPaymentsAmount
Aimmune Therapeutics, Inc.2$35
Novo Nordisk Inc2$33
Novartis Pharmaceuticals Corporation1$33
AstraZeneca Pharmaceuticals LP2$31
Corcept Therapeutics1$29
Amgen Inc.1$22
Otsuka America Pharmaceutical, Inc.1$21
Lilly USA, LLC1$19
Axsome Therapeutics, Inc.1$19

Products named: ZENPEP, ENTRESTO, FARXIGA, Korlym, OTEZLA, REXULTI, ZEPBOUND, Auvelity.

Industry payments across TX — which companies pay providers there.